Rasestumisvastased meetodid

Kasutatud allikad

  • Centers for Disease Control and Prevention. Ten great public achivements. MMWR Morb Mortal Wkly Rep 1999;48:241-3. http://www.cdc.gov/mmwr/preview/mmwrhtml/00056796.htm
  • Dinger et al. Impact of estrogen type on cardiovascular safety of combined oral contraceptives. Contraception 2016;94:328–39.
  • European Society of Contraception and reproductive Health. Teaching and Training Tool for Contraceptive Methods. Kättesaadav: https://escrh.eu/education/training-improvement-programme/
  • Guillebaud J. Contraception – your questions answered. 5th edition. Elsevier, 2009.
  • Guillebaud J. Contraception today. 6th edition. Informa Healthcare, 2007.
  • Hannaford PC, Selvaraj S, Elliott AM, Angus V, Iversen L, Lee AJ. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner’s oral contraception study. British Medical Journal 2007;335:651–9.
  • International Consortium for Emergency Contraception, FIGO. Emergency Contraceptive Pills: Medical and Service Delivery Guidelines, 2012.
  • Jacobstein R, et al. Progestin-only contraception: Injectables and implants. Best Practice & Research in Clinical Obstetrics and Gynaecology 2014; 28: 795-806.
  • Lidegaard Ø, Milson I, Geirsson RT, Skjeldestad FE. Hormonal contraception and venous thromboembolism. Acta Obstetricia et Gynecologica Scandinavica 2012;91:769–78.
  • Long acting resersible contraception. NICE guidelines 2014. Kättesaadav: http://www.nice.org.uk/guidance/cg3
  • Royal College of Obstetricians and Gynaecologists- Faculty of Sexual and Reproductive Healthcare guideline.  Emergency contraception. March 2017. 
  • Sexual rights: an IPPF declaration. http://ippf.org/resources/publications/sexual-rights-ippf-declaration
  • Van Vlijmen E et al. Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemostat 2016;1393–1403.
  • Vessey M, Painter R. Oral contraceptive use and cancer. Findings in a large cohort study, 1968–2004. British Journal of Cancer 2006;95:385–9.
  • World Health Organisation. Medical eligibility criteria for contraceptive use. Geneva: WHO, 2009. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html
  • World Health Organization Department of Reproductive Health and Research (WHO/RHR) and Johns Hopkins Bloomberg School of Public Health/Center for Communication Programs (CCP), Knowledge for Health Project. Family Planning: A Global Handbook for Providers (2011 update). Baltimore and Geneva: CCP and WHO, 2011.
  • WHO. Department of Reproductive Health and Research. Selected practice recommendations for contraceptive use. Third edition, 2016 Kättesaadav: http://www.who.int/reproductivehealth/publications/family_planning/9241562846index/en/index.html
  • WHO. Medical eligibility criteria for contraceptive use. Fifth edition 2015. Kättesaadav:  http://www.who.int/reproductivehealth/publications/family_planning/MECguidelinePart-2.pdf?ua=1